Bursaplex® — The Optimum Product for IBD Protection...
Bursaplex is the first USDA-approved virus- antibody complex vaccine that can be delivered in ovo or at hatch. It contains a live strain of bursal disease virus of chicken embryo origin in conjunction with bursal disease antiserum (antibody).
Bursaplex is an effective, single-dose infectious bursal disease vaccine that safely protects broilers in the presence of maternal antibody.
This complex vaccine works to protect each broiler chick against IBD regardless of the level of maternal antibody present. In fact, Bursaplex works with maternal immunity to protect broilers.
In commercial trials approximately 44 million birds were given Bursaplex. In these trials Bursaplex vaccinates showed an increase in percent of birds processed and body weight. The results of these trials also showed that under these conditions the groups vaccinated with Bursaplex had improved feed conversion ratio and reduced percent condemned birds at processing. These favorable production measures resulted in a reduction in the overall cost of producing each bird by 0.21 cents per pound, or approximately one cent per bird. This does not include the increased cost of Bursaplex compared to the conventional bursal program.
A safe single-dose protection
Bursaplex represents a safe and effective way to give broilers life-long protection against bursal disease in a single dose. Bursaplex when appropriately administered in ovo or at hatch solves the problem of viral vaccine neutralization by maternal antibody, eliminating the need for multiple vaccine dose programs.
The secret lies in the patented antigen-antibody complex technology, which combines the IBD vaccine virus with just enough bursal disease antibody (BDA). This assures that the vaccine virus, an intermediate strain, breaks through to infect the bursa at the appropriate time providing immunity without the risk of causing immunosupression.
This USDA-approved vaccine for in ovo and at hatch vaccination was tested and proved to be safe (not have any negative impact on hatch or post hatch mortality) in both, specific pathogen free (SPF) chickens and broilers with maternal antibody to IBD virus.
Several studies as well as over ten years of commercial field experience with Bursaplex® confirm the safety and effectiveness of this vaccine used as a single dose IBD program.
Convenient and cost effective protection
A single dose of Bursaplex offers convenience besides long life protection — whether delivered in ovo, through the Embrex Inovoject® system, or in an accurate way at hatch. In addition, it has been proven cost effective.
This one dose program with Bursaplex:
Sixteen commercial field trials with a total of 44 million broilers showed that in that case, delivered in ovo or at hatch, Bursaplex was cost effective for poultry producers in a variety of ways. Trials were completed across numerous states, on a variety of breeds and under different management systems. The majority of Bursaplex trials were run against current multiple dose IBD vaccination programs.
A summary of key production parameters from all these field trials showed that the groups vaccinated with Bursaplex presented:
Bursaplex has received regulatory approval in 27 countries including the United States and there are pending registration processes in other countries.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different label indications in other countries.
The animal health information contained herein is provided for educational purposes only and is not intended to replace consultation with your veterinarian. All decisions regarding animal health care must be made with a veterinarian, considering the unique characteristics of each animal's situation.
